Patents by Inventor Stefan Riedmueller

Stefan Riedmueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11958819
    Abstract: The present invention relates to copolymers, particularly to copolymers comprising a photoactive unit, the copolymers being particularly suitable for ophthalmic devices. The copolymers include one or more different polymer units in addition to the photoactive unit, such as polymerized units derived from ethylene, propylene, an acrylate, a methacrylate, or a styrene.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: April 16, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Publication number: 20240117092
    Abstract: The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive chromophore, special polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalmic devices. The present invention is also directed to a process of changing the optical properties of said ophthalmic device or a precursor article for an ophthalmic device.
    Type: Application
    Filed: January 24, 2022
    Publication date: April 11, 2024
    Inventors: Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Simon HELMSTETTER, David MOORE
  • Patent number: 11753387
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: September 12, 2023
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11702396
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: July 18, 2023
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Publication number: 20230203214
    Abstract: The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive chromophore, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalmic devices. The present invention is also directed to a process of changing the optical properties of said ophthalmic device or a precursor article for manufacturing said ophthalmic device.
    Type: Application
    Filed: May 17, 2021
    Publication date: June 29, 2023
    Inventors: Stefan RIEDMUELLER, Stefan GERSTENECKER
  • Publication number: 20220202566
    Abstract: The present invention generally relates to a system for two-photon or multi-photon irradiating an artificial lens, preferably an intraocular lens preferably arranged within an eye of a patient and a method for locally adjusting a polarizability and/or a refractive index of an artificial lens preferably an intraocular lens preferably arranged within an eye of a patient. The method relates in particular to fabrication of optical profiles by adjusting polarizability through two- or multi-photon processes in a non-destructive manner.
    Type: Application
    Filed: April 24, 2020
    Publication date: June 30, 2022
    Applicant: Merck Patent GmbH
    Inventors: Martin SCHRAUB, Lars DOBELMANN-MARA, Simon HELMSTETTER, David MOORE, Stefan RIEDMUELLER, Harald GUENTHER
  • Patent number: 11359031
    Abstract: The present invention relates to a composition for ophthalmological products, to corresponding copolymers and the preparation thereof and to the use thereof for the production of ophthalmic lenses or ophthalmological implants and to these products.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: June 14, 2022
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Lars Dobelmann-Mara, Simon Helmstetter, Stefan Riedmueller, Martin Schraub
  • Publication number: 20210363122
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.
    Type: Application
    Filed: July 30, 2021
    Publication date: November 25, 2021
    Applicant: Merck Patent GmbH
    Inventors: Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Martin SCHRAUB
  • Patent number: 11111226
    Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: September 7, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11078177
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: August 3, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11040990
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11014901
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: May 25, 2021
    Assignee: Merck Patent GmbH
    Inventors: Martin Schraub, Lars Dobelmann-Mara, Stefan Riedmueller
  • Patent number: 11014900
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: May 25, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11001576
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: May 11, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 10829451
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: November 10, 2020
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Publication number: 20200332041
    Abstract: The present invention relates to a composition for ophthalmological products, to corresponding copolymers and the preparation thereof and to the use thereof for the production of ophthalmic lenses or ophthalmological implants and to these products.
    Type: Application
    Filed: December 18, 2018
    Publication date: October 22, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: Lars DOBELMANN-MARA, Simon HELMSTETTER, Stefan RIEDMUELLER, Martin SCHRAUB
  • Publication number: 20200262805
    Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
    Type: Application
    Filed: May 7, 2020
    Publication date: August 20, 2020
    Applicant: Merck Patent GmbH
    Inventors: Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Martin SCHRAUB
  • Patent number: 10723713
    Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: July 28, 2020
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Publication number: 20200231559
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Application
    Filed: February 14, 2018
    Publication date: July 23, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Martin SCHRAUB
  • Publication number: 20200062739
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Application
    Filed: February 14, 2018
    Publication date: February 27, 2020
    Applicant: Merck Patent GmbH
    Inventors: Lars DOBELMANN-MARA, Stefan RIEDMUELLER, Martin SCHRAUB